Intellia Therapeutics, Inc. (NTLA)
USD 8.84
(2.31%)
USD 8.84
(2.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 115.34 Million USD | -11.75% |
| 2022 | 130.7 Million USD | 76.57% |
| 2021 | 74.02 Million USD | 88.33% |
| 2020 | 39.3 Million USD | 113.9% |
| 2019 | 18.37 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 110.86 Million USD | -3.89% |
| 2024 Q2 | 106.29 Million USD | -4.12% |
| 2023 Q1 | 126.12 Million USD | -3.5% |
| 2023 Q3 | 118.33 Million USD | -3.27% |
| 2023 Q4 | 115.34 Million USD | -2.53% |
| 2023 FY | 115.34 Million USD | -11.75% |
| 2023 Q2 | 122.33 Million USD | -3.01% |
| 2022 Q2 | 69.56 Million USD | -3.14% |
| 2022 Q3 | 97.64 Million USD | 40.37% |
| 2022 Q1 | 71.81 Million USD | -2.98% |
| 2022 Q4 | 130.7 Million USD | 33.85% |
| 2022 FY | 130.7 Million USD | 76.57% |
| 2021 Q1 | 72.74 Million USD | 85.07% |
| 2021 FY | 74.02 Million USD | 88.33% |
| 2021 Q4 | 74.02 Million USD | -2.57% |
| 2021 Q3 | 75.97 Million USD | 7.5% |
| 2021 Q2 | 70.67 Million USD | -2.84% |
| 2020 FY | 39.3 Million USD | 113.9% |
| 2020 Q2 | 23.18 Million USD | -4.84% |
| 2020 Q1 | 24.36 Million USD | 32.58% |
| 2020 Q4 | 39.3 Million USD | 77.07% |
| 2020 Q3 | 22.19 Million USD | -4.25% |
| 2019 Q4 | 18.37 Million USD | -6.47% |
| 2019 FY | 18.37 Million USD | 0.0% |
| 2019 Q3 | 19.64 Million USD | -0.11% |
| 2019 Q2 | 19.66 Million USD | 0.8% |
| 2019 Q1 | 19.51 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -81129.577% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1406.334% |
| XOMA Corporation | 124.45 Million USD | 7.315% |
| Mesoblast Limited | 118.92 Million USD | 3.008% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 49.673% |
| Aptorum Group Limited | 3.36 Million USD | -3330.469% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -8778.123% |
| HilleVax, Inc. | 51.19 Million USD | -125.316% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -360.61% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -452.311% |
| Precision BioSciences, Inc. | 31.26 Million USD | -268.895% |
| Dyadic International, Inc. | 136.92 Thousand USD | -84137.817% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -72903.797% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -3916.226% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -2014.5% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -53800.0% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -2009.088% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 49.725% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -828.413% |
| IGM Biosciences, Inc. | 40.5 Million USD | -184.763% |
| Opthea Limited | 200.62 Million USD | 42.508% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -122.783% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -2036.037% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1075.441% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -1770.981% |
| NextCure, Inc. | 6.6 Million USD | -1646.344% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -18444.284% |
| Ovid Therapeutics Inc. | 46 Million USD | -150.743% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -443.086% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -281.738% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -85.817% |
| Senti Biosciences, Inc. | 37.66 Million USD | -206.234% |
| Apollomics, Inc. | 4.66 Million USD | -2374.705% |
| PureTech Health plc | 25.51 Million USD | -352.124% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -36172.327% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -788.918% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -36.224% |
| ChromaDex Corporation | 3.27 Million USD | -3419.866% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -10.716% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -202.714% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -10.089% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -11.407% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -13.771% |
| Fortress Biotech, Inc. | 88.59 Million USD | -30.199% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -82.605% |
| Celcuity Inc. | 37.44 Million USD | -208.031% |
| ContextLogic Inc. | 6 Million USD | -1822.433% |
| GH Research PLC | 343 Thousand USD | -33528.571% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1658.591% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -311645.946% |
| ImmuCell Corporation | 11.96 Million USD | -863.682% |
| Amarin Corporation plc | 8.73 Million USD | -1220.201% |
| TG Therapeutics, Inc. | 110.79 Million USD | -4.108% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -97.914% |
| Acelyrin, Inc. | 1.19 Million USD | -9560.469% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -308.174% |
| Novavax, Inc. | 280.63 Million USD | 58.898% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 17.035% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 98.01% |
| AnaptysBio, Inc. | 17.81 Million USD | -547.502% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2037.224% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -768.177% |
| AbCellera Biologics Inc. | 77.38 Million USD | -49.064% |
| CorMedix Inc. | 667.63 Thousand USD | -17176.883% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -952.907% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.733% |
| Aptose Biosciences Inc. | 1 Million USD | -11322.59% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1332455.453% |
| Soligenix, Inc. | 3.49 Million USD | -3200.729% |
| Century Therapeutics, Inc. | 48.17 Million USD | -139.451% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -0.152% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -25499.961% |
| Kura Oncology, Inc. | 17.2 Million USD | -570.616% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1570.229% |
| Ardelyx, Inc. | 55.98 Million USD | -106.041% |
| Ainos, Inc. | 5.96 Million USD | -1834.182% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -24.789% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -5264.93% |
| Prothena Corporation plc | 11.83 Million USD | -874.618% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -725.433% |
| Autolus Therapeutics plc | 52.96 Million USD | -117.77% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -357.087% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -175.664% |
| Celularity Inc. | 65.41 Million USD | -76.324% |
| Rallybio Corporation | 392 Thousand USD | -29325.0% |
| GRI Bio, Inc. | 14 Thousand USD | -823800.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 65.902% |
| INmune Bio, Inc. | 10.43 Million USD | -1005.164% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 35.786% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1852.681% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -141116.944% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -13850.153% |
| Humacyte, Inc. | 58.1 Million USD | -98.51% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -99.312% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 76.012% |
| Immunocore Holdings plc | 84.03 Million USD | -37.264% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -6124.825% |
| Verastem, Inc. | 41.55 Million USD | -177.561% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -914.298% |
| Histogen Inc. | 4.62 Million USD | -2395.586% |
| Surrozen, Inc. | 3.37 Million USD | -3313.613% |
| Blueprint Medicines Corporation | 774.12 Million USD | 85.1% |
| Organovo Holdings, Inc. | 1.39 Million USD | -8174.462% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -4524.94% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -198772.414% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -36.362% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -55084.193% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -2198.645% |
| Summit Therapeutics Inc. | 106.09 Million USD | -8.715% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -4.52% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -70962.181% |
| Turnstone Biologics Corp. | 3.21 Million USD | -3488.861% |
| Pulmatrix, Inc. | 8.75 Million USD | -1217.337% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -46598.785% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -18.174% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -732.823% |
| Cytokinetics, Incorporated | 755.77 Million USD | 84.738% |
| Exelixis, Inc. | 189.94 Million USD | 39.274% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -276.775% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -3.983% |
| Evogene Ltd. | 1.13 Million USD | -10035.852% |
| Replimune Group, Inc. | 75.86 Million USD | -52.033% |
| PDS Biotechnology Corporation | 23.85 Million USD | -383.598% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -208992.722% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4040.201% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -143493.766% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -235926.192% |
| BioLineRx Ltd. | 11.59 Million USD | -895.134% |
| Avid Bioservices, Inc. | 207.83 Million USD | 44.501% |
| Insmed Incorporated | 1.2 Billion USD | 90.42% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -5340.849% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -151.996% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -177355.385% |
| MediWound Ltd. | 6.71 Million USD | -1618.76% |
| MiMedx Group, Inc. | 48.09 Million USD | -139.81% |
| OmniAb, Inc. | 25.56 Million USD | -351.258% |
| Alector, Inc. | 38.91 Million USD | -196.382% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 46.084% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 72.208% |
| Mereo BioPharma Group plc | 5.95 Million USD | -1837.937% |
| Zai Lab Limited | 15.15 Million USD | -661.309% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 75.891% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -6954.801% |
| Aura Biosciences, Inc. | 19.55 Million USD | -489.794% |
| Immunic, Inc. | 1.33 Million USD | -8546.627% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -320.74% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -263.501% |
| Veracyte, Inc. | 12.63 Million USD | -813.27% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 82.113% |
| FibroGen, Inc. | 170.45 Million USD | 32.331% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1170.191% |
| Allakos Inc. | 41.46 Million USD | -178.177% |
| scPharmaceuticals Inc. | 40.26 Million USD | -186.439% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -965.946% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -76288.079% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -6960.216% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -56466.836% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -2622.351% |
| Precigen, Inc. | 7.09 Million USD | -1525.278% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 93.126% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1476.411% |
| Incyte Corporation | 38.28 Million USD | -201.267% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -38257.376% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -167.209% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -935.608% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4040.201% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 51.664% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -342.906% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -32950.43% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -329.099% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -155.909% |
| Agenus Inc. | 350.24 Million USD | 67.067% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -107809.927% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -8028.682% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -154.987% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -167.196% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -139.163% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -70247.082% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 86.409% |
| UroGen Pharma Ltd. | 100.21 Million USD | -15.1% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -11127.003% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 36.883% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -812539.143% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -37718.361% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -29324.85% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1587.579% |
| Chimerix, Inc. | 2.14 Million USD | -5279.944% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -11754.676% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -224.413% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -66700.253% |
| Pluri Inc. | 29.61 Million USD | -289.525% |
| Cue Biopharma, Inc. | 14.69 Million USD | -684.934% |
| MeiraGTx Holdings plc | 89.26 Million USD | -29.219% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -540162.295% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -2265.101% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -86.59% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -10.807% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1567.573% |
| NLS Pharmaceutics AG | 1.63 Million USD | -6960.216% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -265.621% |
| Nutriband Inc. | 241.28 Thousand USD | -47704.878% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -2009.859% |
| Vor Biopharma Inc. | 35.66 Million USD | -223.46% |
| Roivant Sciences Ltd. | 499.74 Million USD | 76.919% |
| ProKidney Corp. | 4.41 Million USD | -2513.777% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -9308.32% |
| Daré Bioscience, Inc. | 5.31 Million USD | -2068.914% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 93.37% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -20315.221% |
| Bicycle Therapeutics plc | 44.95 Million USD | -156.575% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -196.367% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -60.633% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -31.158% |
| Atai Life Sciences N.V. | 16.47 Million USD | -600.085% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -4606.087% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -16988.296% |
| MediciNova, Inc. | 215.92 Thousand USD | -53319.227% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -4523.086% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -9046.982% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -10009.202% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 38.11% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1020.299% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -106.495% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -3112.981% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1159.098% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -686.218% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -840.985% |
| bluebird bio, Inc. | 330.32 Million USD | 65.081% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -822.325% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -6999.465% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 89.827% |
| BioAtla, Inc. | 2.46 Million USD | -4588.862% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -21.262% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -1979.805% |
| DBV Technologies S.A. | 14.38 Million USD | -702.072% |
| Fortress Biotech, Inc. | 88.59 Million USD | -30.199% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1070.788% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -509.233% |
| aTyr Pharma, Inc. | 15.09 Million USD | -664.134% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -448.014% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -35228.782% |
| Galecto, Inc. | 249 Thousand USD | -46223.695% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -6968.961% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 92.306% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -8.751% |
| Entera Bio Ltd. | 390 Thousand USD | -29475.897% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 71.504% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -1758.022% |
| Xencor, Inc. | 83.43 Million USD | -38.248% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -6737.344% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -2402.625% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -9321.953% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1126.563% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -70247.082% |
| Portage Biotech Inc. | 47 Thousand USD | -245317.021% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -9046.982% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -4672.28% |
| OncoCyte Corporation | 2.86 Million USD | -3920.425% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -76514.371% |
| Purple Biotech Ltd. | 351 Thousand USD | -32762.108% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -3551.345% |
| Onconetix, Inc. | 9.88 Million USD | -1066.788% |
| MacroGenics, Inc. | 33.97 Million USD | -239.543% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -5570.898% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -2105.047% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -746.079% |
| Aditxt, Inc. | 18.21 Million USD | -533.143% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -331.394% |
| Curis, Inc. | 2.79 Million USD | -4028.346% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -5298.959% |
| Adagene Inc. | 22.3 Million USD | -417.087% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -589.415% |
| BeiGene, Ltd. | 930.18 Million USD | 87.6% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 45.11% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -14168.396% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 81.121% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -151671.053% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -4510.152% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -40.637% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 43.984% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -2383.764% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 95.7% |
| ADMA Biologics, Inc. | 141.41 Million USD | 18.436% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -90.406% |
| Clene Inc. | 32.16 Million USD | -258.652% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -4437.608% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -511.818% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -5154.943% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -127.633% |
| Adicet Bio, Inc. | 20.92 Million USD | -451.262% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 40.295% |
| Absci Corporation | 15.95 Million USD | -622.855% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -653.748% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -468.403% |
| Surrozen, Inc. | 3.37 Million USD | -3313.613% |
| Generation Bio Co. | 97.89 Million USD | -17.827% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -34959.574% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -319.669% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -355.949% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -369.994% |
| Invivyd, Inc. | 2.16 Million USD | -5227.76% |
| Cingulate Inc. | 3.13 Million USD | -3579.182% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -115.737% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -3273306.305% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -22927.612% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -1980.931% |
| Jaguar Health, Inc. | 35.86 Million USD | -221.656% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -182988.889% |
| 2seventy bio, Inc. | 256.67 Million USD | 55.061% |
| Clearside Biomedical, Inc. | 43 Million USD | -168.24% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -19028.69% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -101.636% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -1955.289% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -23868.249% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -307.987% |
| Innoviva, Inc. | 449.07 Million USD | 74.315% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -470.483% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -69.055% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -570.733% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 7.382% |
| Evaxion Biotech A/S | 10.86 Million USD | -961.172% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -38.323% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -53.986% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1675.647% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -281231.707% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -327.366% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -24705.591% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -320.526% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1029.404% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -3142.789% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -7317.749% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -9054.444% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -698.574% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -12631.347% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -122.986% |
| ImmunityBio, Inc. | 883.67 Million USD | 86.947% |
| Korro Bio, Inc. | 33.2 Million USD | -247.354% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -62.514% |
| Kineta, Inc. | 1.31 Million USD | -8658.238% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -49094.143% |
| BioVie Inc. | 6.11 Million USD | -1787.376% |
| Codexis, Inc. | 22.36 Million USD | -415.766% |
| Celularity Inc. | 65.41 Million USD | -76.324% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -30016.449% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -51324.877% |
| Kodiak Sciences Inc. | 181.63 Million USD | 36.495% |
| Cibus, Inc. | 24.62 Million USD | -368.486% |
| Annexon, Inc. | 31.35 Million USD | -267.871% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -4825.107% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 92.064% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -53.721% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -2855.316% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -616.09% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -3.459% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -150.54% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -259.132% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -11610.254% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -906.773% |
| Alkermes plc | 290.73 Million USD | 60.325% |
| Arcellx, Inc. | 97.62 Million USD | -18.152% |
| Moolec Science SA | 2.64 Million USD | -4260.431% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -5267.427% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -1727.119% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -335.055% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -3618.44% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -4702.082% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -6555.857% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -98.51% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -304.908% |
| Geron Corporation | 85.89 Million USD | -34.281% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -153.452% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 98.12% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -99979.824% |
| Notable Labs, Ltd. | 2.04 Million USD | -5529.38% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -240.958% |
| Structure Therapeutics Inc. | 5.45 Million USD | -2015.276% |
| IN8bio, Inc. | 4.89 Million USD | -2257.368% |
| 89bio, Inc. | 27.1 Million USD | -325.505% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -28736.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -114.765% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -4479.039% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -8520.777% |
| Liquidia Corporation | 3.5 Million USD | -3192.778% |
| Mustang Bio, Inc. | 2.49 Million USD | -4517.534% |
| Immunovant, Inc. | 138 Thousand USD | -83484.058% |
| Vericel Corporation | 88.14 Million USD | -30.862% |
| Quantum-Si incorporated | 15.3 Million USD | -653.748% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1222.624% |
| XOMA Corporation | 124.45 Million USD | 7.315% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -41997.08% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -141116.944% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -768.831% |
| Vaxcyte, Inc. | 29.22 Million USD | -294.696% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -957.929% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -56720.69% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -458.279% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -6877.979% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -9054.444% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -28521.836% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -11076.938% |
| PepGen Inc. | 20.1 Million USD | -473.747% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -19995.122% |
| United Therapeutics Corporation | 700 Million USD | 83.522% |
| Solid Biosciences Inc. | 26.26 Million USD | -339.162% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -11610.254% |
| Immuneering Corporation | 4.46 Million USD | -2484.518% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -114103.96% |
| Belite Bio, Inc | 886 Thousand USD | -12918.736% |
| Pharming Group N.V. | 171.54 Million USD | 32.761% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 51.863% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -440.744% |
| uniQure N.V. | 138.4 Million USD | 16.663% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -585.359% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -35.029% |
| Altimmune, Inc. | 671 Thousand USD | -17090.164% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -768.831% |
| Peak Bio, Inc. | 10.72 Million USD | -975.807% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1170.191% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -6502.519% |
| Benitec Biopharma Inc. | 284 Thousand USD | -40514.789% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 74.083% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -39723.507% |
| Compugen Ltd. | 1.35 Million USD | -8437.824% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -54699.063% |
| argenx SE | 20 Million USD | -476.73% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -169.714% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -36.415% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -479.017% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | 1.576% |
| PolyPid Ltd. | 11.77 Million USD | -879.251% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -26.119% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -2658.814% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -19617.265% |
| Instil Bio, Inc. | 86.05 Million USD | -34.039% |
| Elevation Oncology, Inc. | 30.13 Million USD | -282.739% |
| Immunome, Inc. | 1.65 Million USD | -6890.667% |
| Verona Pharma plc | 51.32 Million USD | -124.719% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1079.648% |
| Shattuck Labs, Inc. | 4.2 Million USD | -2645.026% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -31763.536% |
| Design Therapeutics, Inc. | 3.05 Million USD | -3681.836% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -43925.191% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -710.697% |
| Achilles Therapeutics plc | 4.61 Million USD | -2399.372% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 69.136% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -283.222% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -3019.259% |
| Beam Therapeutics Inc. | 173.17 Million USD | 33.393% |
| Moolec Science SA | 2.64 Million USD | -4260.431% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -24183.368% |
| AEON Biopharma, Inc. | 278 Thousand USD | -41391.367% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1542.17% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -34331.642% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -52.047% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -88.761% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -281.824% |
| Athira Pharma, Inc. | 1.58 Million USD | -7177.35% |
| HCW Biologics Inc. | 6.45 Million USD | -1687.818% |
| XOMA Corporation | 124.45 Million USD | 7.315% |
| NeurAxis, Inc. | 224.26 Thousand USD | -51334.05% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1651.648% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1079.648% |
| 180 Life Sciences Corp. | 1.32 Million USD | -8637.877% |
| Nektar Therapeutics | 230.4 Million USD | 49.937% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -479.017% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -575.323% |
| Arvinas, Inc. | 3.4 Million USD | -3292.529% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -7317.749% |
| Palisade Bio, Inc. | 369 Thousand USD | -31159.079% |
| Nutriband Inc. | 241.28 Thousand USD | -47704.878% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -6968.961% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -13864.407% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -27694.217% |
| Merus N.V. | 12.16 Million USD | -848.413% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 10.186% |
| Neurogene Inc. | 16.25 Million USD | -609.603% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 62.567% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -304.141% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -734.993% |
| Rezolute, Inc. | 2.22 Million USD | -5077.11% |
| Clene Inc. | 32.16 Million USD | -258.652% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -65792.044% |
| BeyondSpring Inc. | 3.99 Million USD | -2787.259% |
| Synlogic, Inc. | 17.27 Million USD | -567.705% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -8772.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -329460.0% |
| Peak Bio, Inc. | 10.72 Million USD | -975.807% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -122.148% |
| Krystal Biotech, Inc. | 8.09 Million USD | -1325.08% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 34.839% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1534.491% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -84344.412% |
| MannKind Corporation | 382.37 Million USD | 69.835% |
| Ikena Oncology, Inc. | 10.73 Million USD | -974.185% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -28101.956% |
| Gossamer Bio, Inc. | 212.46 Million USD | 45.71% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -66190.805% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1159.098% |
| Legend Biotech Corporation | 328.67 Million USD | 64.905% |
| Mural Oncology plc | 15 Million USD | -668.512% |
| Disc Medicine, Inc. | 2.1 Million USD | -5390.052% |
| Champions Oncology, Inc. | 7.43 Million USD | -1452.436% |
| REGENXBIO Inc. | 89.29 Million USD | -29.181% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -13395.543% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -20758.907% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -2030.513% |
| Vaxart, Inc. | 26.51 Million USD | -335.038% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -636.689% |
| Cellectis S.A. | 92.85 Million USD | -24.224% |
| Longeveron Inc. | 2.04 Million USD | -5551.445% |
| Repare Therapeutics Inc. | 3.41 Million USD | -3282.581% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 91.742% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -147.566% |
| Revolution Medicines, Inc. | 87.94 Million USD | -31.158% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -66573.988% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -2817.936% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -36286.751% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -65812.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 85.732% |
| Denali Therapeutics Inc. | 52.24 Million USD | -120.796% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -700.71% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -8294.905% |
| Cingulate Inc. | 3.13 Million USD | -3579.182% |
| Passage Bio, Inc. | 26.29 Million USD | -338.678% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1630.623% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -28171.078% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -12802.237% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -460.994% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -4605.847% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -3593.436% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -14122.688% |
| OmniAb, Inc. | 25.56 Million USD | -351.258% |
| Anew Medical, Inc. | 1.6 Million USD | -7086.667% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -289.908% |
| Lipocine Inc. | 17.16 Thousand USD | -671844.542% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -891.115% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -233.1% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1852.681% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -101.749% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -56720.69% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -2133.224% |
| Ocugen, Inc. | 6.94 Million USD | -1561.807% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -716.378% |
| Q32 Bio Inc. | 1.31 Million USD | -8651.593% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -17064.583% |
| Alumis Inc. Common Stock | 32.58 Million USD | -254.039% |
| Equillium, Inc. | 824 Thousand USD | -13898.301% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1170.47% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -38245.645% |
| Dominari Holdings Inc. | 3.02 Million USD | -3709.313% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -121976.053% |
| vTv Therapeutics Inc. | 529 Thousand USD | -21704.537% |
| Bio-Techne Corporation | 419.53 Million USD | 72.506% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -60.212% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 40.41% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -583.006% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -406.748% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -1804.028% |
| Nkarta, Inc. | 88.33 Million USD | -30.572% |
| BioCardia, Inc. | 1.31 Million USD | -8671.559% |
| Iterum Therapeutics plc | 19.5 Million USD | -491.245% |